Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers

Prostate specific antigen (PSA) remains the most used biomarker in the management of early prostate cancer (PCa), in spite of the problems related to false positive results and overdiagnosis. New biomarkers have been proposed in recent years with the aim of increasing specificity and distinguishing...

Descripción completa

Detalles Bibliográficos
Autores principales: Filella, Xavier, Foj, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133785/
https://www.ncbi.nlm.nih.gov/pubmed/27792187
http://dx.doi.org/10.3390/ijms17111784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133785/
https://www.ncbi.nlm.nih.gov/pubmed/27792187
http://dx.doi.org/10.3390/ijms17111784

Ejemplares similares